Nasdaq:US$16.21 (-0.64) | HKEX:HK$26.45 (+1.00) | AIM:£2.72 (+0.05)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF